Biotechnology and Development ApS: Financial statements 2026
CVR: 33870639
Source: annual report 2026, Danish Business Authority
01/07/2025 – 30/06/2026
Biotechnology and Development ApS (CVR 33870639) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK 268,463 and a net result of DKK -54,610 compared with DKK -1,709 the year before. That is a decrease of 4.9% compared with the year before. Equity in the 2026 report amounted to DKK 50,608. The solvency ratio was 21.9%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 268,463
- Profit/Loss
- DKK -54,610
- Equity
- DKK 50,608
- Total Assets
- DKK 231,106
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2026 | - | 268 t. | -55 t. | 51 t. | 1 |
| 2025 | - | 282 t. | -2 t. | 105 t. | 1 |
| 2024 | - | 108 t. | 66 t. | 107 t. | 1 |
| 2023 | - | 3 t. | -15 t. | 41 t. | 1 |
| 2022 | - | 45 t. | 19 t. | 55 t. | 1 |
Official annual report
Find more companies like Biotechnology and Development ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorAbout Biotechnology and Development ApS
Biotechnology and Development ApS is a Danish company of the type Anpartsselskab based in Silkeborg, founded in 2011. The company is registered under the industry Engroshandel med andre råvarer og halvfabrikata. The management consists of Karl Erik Molbech. The company is owned by KLMC Holding ApS. The company has 1 employee (2018). In 2026, the company reported a gross profit of DKK 268,463 and a net result of DKK -54,610 compared with DKK -1,709 the year before. Equity in the 2026 report amounted to DKK 50,608.